Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar V Parikh

Showing results (71-80 of 188) with videos related to

Pageof 19
Sort By:
JMIR Medical Education|November 1, 2023
Preliminary Evaluation of a Web-Based International Journal Club for Ketamine in Psychiatric Disorders: Cross-Sectional Survey StudyJacek R Lindner, Ashkan Ebrahimi, Julian F Kochanowicz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 19, 2004
Chronic lithium treatment attenuates intracellular calcium mobilizationMichael J Wasserman, Timothy W Corson, David Sibony, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 20, 2009
Effects on knowledge and attitudes of using stages of change to train general practitioners on management of depression: a randomized controlled studyMandana Shirazi, Sagar V Parikh, Farshid Alaeddini, et al.
Journal of Affective Disorders|August 14, 2009
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. PharmacotherapyRaymond W Lam, Sidney H Kennedy, Sophie Grigoriadis, et al.
Npj Mental Health Research|June 23, 2025
Development of the treatment prediction model in the artificial intelligence in depression - medication enhancement studyDavid Benrimoh, Caitrin Armstrong, Joseph Mehltretter, et al.
Psychopharmacology Bulletin|April 26, 2021
Going Virtual During a Pandemic: An Academic Psychiatry Department's Experience with TelepsychiatrySagar V Parikh, Danielle S Taubman, Mary Grambeau, et al.
The Journal of Clinical Psychiatry|January 5, 2022
The Effects of Ketamine on Cognition in Unipolar and Bipolar Depression: A Systematic ReviewSophie R Vaccarino, Fathima Adamsahib, Roumen V Milev, et al.
The American Journal of Psychiatry|May 3, 2023
Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 TrialAnita H Clayton, Robert Lasser, Sagar V Parikh, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 14, 2013
Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorderRaymond W Lam, Sagar V Parikh, Rajamannar Ramasubbu, et al.
Current Pharmaceutical Design|June 12, 2012
The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response predictionSidney H Kennedy, Jonathan Downar, Kenneth R Evans, et al.
Pageof 19

Showing results (71-80 of 188) with videos related to

Sort By:
Pageof 19
JMIR Medical Education|November 1, 2023
Preliminary Evaluation of a Web-Based International Journal Club for Ketamine in Psychiatric Disorders: Cross-Sectional Survey StudyJacek R Lindner, Ashkan Ebrahimi, Julian F Kochanowicz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 19, 2004
Chronic lithium treatment attenuates intracellular calcium mobilizationMichael J Wasserman, Timothy W Corson, David Sibony, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 20, 2009
Effects on knowledge and attitudes of using stages of change to train general practitioners on management of depression: a randomized controlled studyMandana Shirazi, Sagar V Parikh, Farshid Alaeddini, et al.
Journal of Affective Disorders|August 14, 2009
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. PharmacotherapyRaymond W Lam, Sidney H Kennedy, Sophie Grigoriadis, et al.
Npj Mental Health Research|June 23, 2025
Development of the treatment prediction model in the artificial intelligence in depression - medication enhancement studyDavid Benrimoh, Caitrin Armstrong, Joseph Mehltretter, et al.
Psychopharmacology Bulletin|April 26, 2021
Going Virtual During a Pandemic: An Academic Psychiatry Department's Experience with TelepsychiatrySagar V Parikh, Danielle S Taubman, Mary Grambeau, et al.
The Journal of Clinical Psychiatry|January 5, 2022
The Effects of Ketamine on Cognition in Unipolar and Bipolar Depression: A Systematic ReviewSophie R Vaccarino, Fathima Adamsahib, Roumen V Milev, et al.
The American Journal of Psychiatry|May 3, 2023
Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 TrialAnita H Clayton, Robert Lasser, Sagar V Parikh, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 14, 2013
Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorderRaymond W Lam, Sagar V Parikh, Rajamannar Ramasubbu, et al.
Current Pharmaceutical Design|June 12, 2012
The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response predictionSidney H Kennedy, Jonathan Downar, Kenneth R Evans, et al.
Pageof 19